Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
bioAffinity Technologies, Inc. - Common Stock
(NQ:
BIAF
)
2.450
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, May 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about bioAffinity Technologies, Inc. - Common Stock
< Previous
1
2
Next >
bioAffinity Technologies to Ring Nasdaq Closing Bell Today
April 05, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
March 31, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer
March 28, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023
March 24, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications
February 13, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research
January 24, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments
January 04, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Expands Diagnostic Division with Promotions and New Hires to Strengthen Clinical Bench
December 15, 2022
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
December 01, 2022
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board
November 10, 2022
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies to Report Third Quarter 2022 Financial Results
November 08, 2022
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and Australia
October 25, 2022
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference
October 12, 2022
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6M
September 28, 2022
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONE
September 14, 2022
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offering
September 06, 2022
From
bioAffinity Technologies, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.